{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:34:15Z","timestamp":1780450455137,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Durch die Optimierung medizinischer Versorgungsstrukturen und die gravierenden Fortschritte bei der Entwicklung neuer Therapieverfahren wird ein Anstieg der Lebenserwartung bei Patienten mit neuromuskul\u00e4ren Erkrankungen beobachtet. Dies f\u00fchrt zu einer Erweiterung des ph\u00e4notypischen Spektrums, wodurch neue bzw. bislang wenig relevante Krankheitsmanifestationen in unterschiedlichen Organsystemen an Bedeutung gewinnen. Die Betreuung jugendlicher und junger Erwachsener mit neuromuskul\u00e4ren Erkrankungen verlangt daher eine zunehmend enge interdisziplin\u00e4re Zusammenarbeit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Fragestellung<\/jats:title>\n                <jats:p>Wie kann der Transitionsprozess von der P\u00e4diatrie in die Erwachsenenmedizin so strukturiert werden, dass die einzelnen Fachdisziplinen effizient in den komplexen Behandlungs- und Versorgungsprozess eingebunden und die Lebensqualit\u00e4t der Patienten verbessert werden?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methode<\/jats:title>\n                <jats:p>An der Universit\u00e4tsmedizin Essen wurde ein strukturierter Transitionsprozess etabliert. Exemplarisch wurde anhand des Morbus Pompe (\u201elate onset M. Pompe\u201c [LOPD]), der Duchenne-Muskeldystrophie (DMD) und der juvenilen Myasthenia gravis (jMG) ein entsprechendes Versorgungskonzept entwickelt. Dies umfasst vier Elemente: 1)\u00a0Mit der Einf\u00fchrung klinik\u00fcbergreifender SOPs (\u201estandard operating procedure\u201c) werden die logistischen Abl\u00e4ufe sowie die diagnostischen und therapeutischen Ma\u00dfnahmen einheitlich abgestimmt und der Transitionsprozess verbindlich festgelegt. 2)\u00a0Um einen nahtlosen \u00dcbergang zu gew\u00e4hrleisten, werden junge Patienten vor Erreichen des 17.\u00a0Geburtstages mit ihren Eltern im Zuge gemeinsamer Transitionssprechstunden betreut. Dies schafft die M\u00f6glichkeit des gegenseitigen Kennenlernens und der Bildung eines nachhaltigen Vertrauensverh\u00e4ltnisses. 3)\u00a0Ein quartalsweise stattfindendes \u201eTransitionsboard\u201c bringt die beteiligten Fachdisziplinen aus Kinder- und Erwachsenenmedizin f\u00fcr einen fallbezogenen interdisziplin\u00e4ren Austausch und eine stetige Optimierung des Transitionsprozesses regelm\u00e4\u00dfig zusammen. 4)\u00a0Als gemeinsame Informationsplattform und Datengrundlage wurde eine klinik\u00fcbergreifende \u201eTransitionsdatenbank\u201c, in der medizinische Befunde und Verlaufsparameter erfasst werden, implementiert.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Mit dem Essener Transitionsmodell soll die Versorgungsl\u00fccke junger Patienten mit neuromuskul\u00e4ren Erkrankungen w\u00e4hrend der kritischen \u00dcbergangsphase von der Kinder- zur Erwachsenenmedizin geschlossen und die Grundlage f\u00fcr eine erfolgreiche Weiterbehandlung im Erwachsenenalter geschaffen werden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00115-022-01274-6","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T14:02:47Z","timestamp":1646661767000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201eEssener Transitionsmodell\u201c bei neuromuskul\u00e4ren Erkrankungen","Essen transition model for neuromuscular diseases"],"prefix":"10.1007","volume":"94","author":[{"given":"Michael","family":"Fleischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayram","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Stolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Della-Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nonnemacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hagenacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"6","key":"1274_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00103-008-0535-4","volume":"51","author":"C Scheidt-Nave","year":"2008","unstructured":"Scheidt-Nave\u00a0C, Ellert\u00a0U, Thyen\u00a0U, Schlaud\u00a0M (2008) Health care needs of children and adolescents with chronic conditions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(6):592\u2013601. https:\/\/doi.org\/10.1007\/s00103-008-0535-4","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"10","key":"1274_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00115-018-0585-2","volume":"89","author":"U Schara","year":"2018","unstructured":"Schara\u00a0U, Fink\u00a0GR, von Moers\u00a0A (2018) Transition from neuropediatrics to neurology in neuromuscular diseases. Nervenarzt 89(10):1123\u20131130. https:\/\/doi.org\/10.1007\/s00115-018-0585-2","journal-title":"Nervenarzt"},{"key":"1274_CR3","volume-title":"Tranistionsmedizin: multiprofessionelle Begleitung junger Erwachsener mit chronischer Krankheit","author":"M Oldhafer","year":"2016","unstructured":"Oldhafer\u00a0M, Berlien\u00a0H (2016) Tranistionsmedizin: multiprofessionelle Begleitung junger Erwachsener mit chronischer Krankheit. Schattauer, Stuttgart"},{"key":"1274_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00608-016-0380-x","volume":"51","author":"T Thun-Hohenstein","year":"2016","unstructured":"Thun-Hohenstein\u00a0T (2016) Transitionsmedizin: \u00dcbergang von kinder- und jungendmedizinische in erwachenenmedizininsche Betreuung. P\u00e4diatrie P\u00e4diologie 51:10\u201315. https:\/\/doi.org\/10.1007\/s00608-016-0380-x","journal-title":"P\u00e4diatrie P\u00e4diologie"},{"issue":"4","key":"1274_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00103-012-1460-0","volume":"55","author":"H von der Hardt","year":"2012","unstructured":"von der Hardt\u00a0H, Schwarz\u00a0C, Ulrich\u00a0G (2012) Erwachsene mit Mukoviszidose: Es geht um mehr als die Lebensdauer. Bundesgesundheitsbl 55(4):558\u2013567. https:\/\/doi.org\/10.1007\/s00103-012-1460-0","journal-title":"Bundesgesundheitsbl"},{"issue":"6","key":"1274_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/archdischild-2014-307320","volume":"100","author":"CM Hepburn","year":"2015","unstructured":"Hepburn\u00a0CM, Cohen\u00a0E, Bhawra\u00a0J, Weiser\u00a0N, Hayeems\u00a0RZ, Guttmann\u00a0A (2015) Health system strategies supporting transition to adult care. Arch Dis Child 100(6):559\u2013564. https:\/\/doi.org\/10.1136\/archdischild-2014-307320","journal-title":"Arch Dis Child"},{"key":"1274_CR7","volume-title":"Transition \u2013 Definition, Epidemiologie und aktueller Bedarf. Medizinische Versorgung in der Transition \u2013 Spezielle Anforderungen beim \u00dcbergang vom Kindes- und Jugendalter zum Erwachsenenalter","author":"PC Scriba","year":"2012","unstructured":"Scriba\u00a0PC (2012) Transition \u2013 Definition, Epidemiologie und aktueller Bedarf. Medizinische Versorgung in der Transition \u2013 Spezielle Anforderungen beim \u00dcbergang vom Kindes- und Jugendalter zum Erwachsenenalter. Deutscher \u00c4rzte-Verlag, K\u00f6ln"},{"issue":"6","key":"1274_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jcjd.2015.08.003","volume":"39","author":"S Wafa","year":"2015","unstructured":"Wafa\u00a0S, Nakhla\u00a0M (2015) Improving the transition from pediatric to adult diabetes healthcare: a literature review. Can J Diabetes 39(6):520\u2013528. https:\/\/doi.org\/10.1016\/j.jcjd.2015.08.003","journal-title":"Can J Diabetes"},{"issue":"1","key":"1274_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00608-016-0348-x","volume":"51","author":"S M\u00fcther","year":"2016","unstructured":"M\u00fcther\u00a0S, Findorff\u00a0J (2016) Berliner Transitionsprogramm. P\u00e4diatrie P\u00e4dologie 51(1):25\u201329. https:\/\/doi.org\/10.1007\/s00608-016-0348-x","journal-title":"P\u00e4diatrie P\u00e4dologie"},{"issue":"4","key":"1274_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00467-014-2859-7","volume":"30","author":"BJ Foster","year":"2015","unstructured":"Foster\u00a0BJ (2015) Heightened graft failure risk during emerging adulthood and transition to adult care. Pediatr Nephrol 30(4):567\u2013576. https:\/\/doi.org\/10.1007\/s00467-014-2859-7","journal-title":"Pediatr Nephrol"},{"key":"1274_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12687","author":"TM Kapellen","year":"2018","unstructured":"Kapellen\u00a0TM, Muther\u00a0S, Schwandt\u00a0A, Grulich-Henn\u00a0J, Schenk\u00a0B, Schwab\u00a0KO et al (2018) Transition to adult diabetes care in Germany-high risk for acute complications and declining metabolic control during the transition phase. Pediatr Diabetes. https:\/\/doi.org\/10.1111\/pedi.12687","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"1274_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2337\/dc07-2247","volume":"31","author":"N Van Walleghem","year":"2008","unstructured":"Van Walleghem\u00a0N, Macdonald\u00a0CA, Dean\u00a0HJ (2008) Evaluation of a\u00a0systems navigator model for transition from pediatric to adult care for young adults with type 1 diabetes. Diabetes Care 31(8):1529\u20131530. https:\/\/doi.org\/10.2337\/dc07-2247","journal-title":"Diabetes Care"},{"key":"1274_CR13","volume-title":"Besondere Anforderungen an die Transitionsversorgung und an die Arzneimittelversorgung bei Kindern und bei \u00e4lteren Menschen","author":"G Glaeske","year":"2010","unstructured":"Glaeske\u00a0G (2010) Besondere Anforderungen an die Transitionsversorgung und an die Arzneimittelversorgung bei Kindern und bei \u00e4lteren Menschen"},{"issue":"3","key":"1274_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1024\/1661-4747\/a000236","volume":"63","author":"I Seiffge-Krenke","year":"2015","unstructured":"Seiffge-Krenke\u00a0I (2015) \u201cEmerging Adulthood\u201d: Forschungsbefunde zu objektiven Markern, Entwicklungsaufgaben und Entwicklungsrisiken. Z\u00a0Psychiatr Psychol Psychother 63(3):165\u2013173. https:\/\/doi.org\/10.1024\/1661-4747\/a000236","journal-title":"Z Psychiatr Psychol Psychother"},{"issue":"4","key":"1274_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00008480-200108000-00004","volume":"13","author":"ST Callahan","year":"2001","unstructured":"Callahan\u00a0ST, Winitzer\u00a0RF, Keenan\u00a0P (2001) Transition from pediatric to adult-oriented health care: a\u00a0challenge for patients with chronic disease. Curr Opin Pediatr 13(4):310\u2013316. https:\/\/doi.org\/10.1097\/00008480-200108000-00004","journal-title":"Curr Opin Pediatr"},{"key":"1274_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-007-0247-1","volume-title":"Inanspruchnahme medizinischer Leistungen : Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS)","author":"P Kamtsiuris","year":"2007","unstructured":"Kamtsiuris\u00a0P, Bergmann\u00a0E, Rattay\u00a0P, Schlaud\u00a0M (2007) Inanspruchnahme medizinischer Leistungen : Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Robert Koch-Institut,"},{"issue":"8","key":"1274_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s00112-012-2687-4","volume":"160","author":"M Schwarz","year":"2012","unstructured":"Schwarz\u00a0M (2012) Transition bei angeborenen Stoffwechselkrankheiten. Monatsschr Kinderheilkd 160(8):750\u2013755. https:\/\/doi.org\/10.1007\/s00112-012-2687-4","journal-title":"Monatsschr. Kinderheilkd."},{"issue":"6","key":"1274_CR18","doi-asserted-by":"publisher","first-page":"e015593","DOI":"10.1136\/bmjopen-2016-015593","volume":"7","author":"J Prufe","year":"2017","unstructured":"Prufe\u00a0J, Dierks\u00a0ML, Bethe\u00a0D, Oldhafer\u00a0M, Muther\u00a0S, Thumfart\u00a0J et al (2017) Transition structures and timing of transfer from paediatric to adult-based care after kidney transplantation in Germany: a\u00a0qualitative study. BMJ Open 7(6):e15593. https:\/\/doi.org\/10.1136\/bmjopen-2016-015593","journal-title":"BMJ Open"},{"issue":"4","key":"1274_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant\u00a0DJ, Bushby\u00a0K, Bann\u00a0CM, Alman\u00a0BA, Apkon\u00a0SD, Blackwell\u00a0A et\u00a0al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347\u2013361. https:\/\/doi.org\/10.1016\/S1474-4422(18)30025-5","journal-title":"Lancet Neurol"},{"issue":"5","key":"1274_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s1474-4422(18)30026-7","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant\u00a0DJ, Bushby\u00a0K, Bann\u00a0CM, Apkon\u00a0SD, Blackwell\u00a0A, Colvin\u00a0MK et\u00a0al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol 17(5):445\u2013455. https:\/\/doi.org\/10.1016\/s1474-4422(18)30026-7","journal-title":"Lancet Neurol"},{"key":"1274_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-45188-1","volume-title":"Angeborene Stoffwechselkrankheiten bei Erwachsenen","author":"S Vom Dahl","year":"2014","unstructured":"Vom Dahl\u00a0S (2014) Angeborene Stoffwechselkrankheiten bei Erwachsenen. Springer,"},{"issue":"2","key":"1274_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1542\/peds.2008-0740","volume":"123","author":"NG Peter","year":"2009","unstructured":"Peter\u00a0NG, Forke\u00a0CM, Ginsburg\u00a0KR, Schwarz\u00a0DF (2009) Transition from pediatric to adult care: internists\u2019 perspectives. Pediatrics 123(2):417\u2013423. https:\/\/doi.org\/10.1542\/peds.2008-0740","journal-title":"Pediatrics"},{"key":"1274_CR23","volume-title":"Koordination und Integration: Gesundheitsversorgung in einer Gesellschaft des l\u00e4ngeren Lebens","author":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen","year":"2009","unstructured":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen (2009) Koordination und Integration: Gesundheitsversorgung in einer Gesellschaft des l\u00e4ngeren Lebens, 1.\u00a0Aufl.","edition":"1"},{"issue":"7","key":"1274_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/1054-139x(93)90143-d","volume":"14","author":"RW Blum","year":"1993","unstructured":"Blum\u00a0RW, Garell\u00a0D, Hodgman\u00a0CH, Jorissen\u00a0TW, Okinow\u00a0NA, Orr\u00a0DP et al (1993) Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the society for adolescent medicine. J\u00a0Adolesc Health 14(7):570\u2013576. https:\/\/doi.org\/10.1016\/1054-139x(93)90143-d","journal-title":"J Adolesc Health"},{"issue":"3","key":"1274_CR25","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1542\/peds.2017-1284H","volume":"141","author":"P Lozano","year":"2018","unstructured":"Lozano\u00a0P, Houtrow\u00a0A (2018) Supporting self-management in children and adolescents with complex chronic conditions. Pediatrics 141(3):S233\u2013s41. https:\/\/doi.org\/10.1542\/peds.2017-1284H","journal-title":"Pediatrics"},{"issue":"1","key":"1274_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1542\/peds.2011-0969","volume":"128","author":"WC Cooley","year":"2011","unstructured":"Cooley\u00a0WC, Sagerman\u00a0PJ (2011) Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 128(1):182\u2013200. https:\/\/doi.org\/10.1542\/peds.2011-0969","journal-title":"Pediatrics"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-022-01274-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:05:01Z","timestamp":1675425901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-022-01274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s00115-022-01274-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"24 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die Publikation wurde unterst\u00fctzt von Sanofi Genzyme\/Sanofi-Aventis Deutschland GmbH. T.\u00a0Hagenacker hat Vortrags- und Beraterhonorare von Biogen, Roche, Novartis Gene therapies, Sanofi-Genzyme und Alexion erhalten. U.\u00a0Schara-Schmidt hat Vortrags- und Beraterhonorare von Biogen, Roche, Novartis Gene therapies, Sanofi-Genzyme und Alexion erhalten. H.\u00a0K\u00f6lbel hat Vortragshonorare von Pfizer, Roche, Novartis und Sanofi und ist im Advisory Board (Avexis\/Novartis). M.\u00a0Fleischer, B.\u00a0Coskun, B.\u00a0Stolte, A.\u00a0Della-Marina, H.\u00a0Lax, M.\u00a0Nonnemacher und C.\u00a0Kleinschnitz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}